Pulmonary Vascular Resistance Abnormality
7 clinical trials · Condition
◉ Watch Pulmonary Vascular Resistance Abnormality
| Record | Firm | Date |
|---|---|---|
| Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents (NCT04718350) | Aretaieion University Hospital | 2021-01-27 |
| Levosimendan Administration in Pulmonary Hypertension (NCT04599816) | Aretaieion University Hospital | 2020-10-17 |
| PV Loop and Pulmonary Hypertension (NCT05484596) | Hythem Nawaytou | 2020-04-27 |
| ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis (NCT03404258) | University of Colorado, Denver | 2018-02-10 |
| Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure (NCT02775539) | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | 2016-06-01 |
| Iron Status and Cardiopulmonary Physiology (NCT03707249) | Royal Centre for Defence Medicine | 2016-01-19 |
Track Pulmonary Vascular Resistance Abnormality automatically
Every clearance here is in the API, with alerts when new ones post.